Introduction
============

There are increasing evidences that alterations induced by diabetes in the cardiovascular autonomic system may show gender differences \[[@B1]\]. Generally, cardiovascular diseases are more frequently found in men than premenopausal women \[[@B2]\]. However, in the diabetic patients, the incidence of cardiovascular disease becomes similar between men and women because diabetes may produce a relatively greater impairment in the female cardiovascular system \[[@B1]\]. In addition, in female rats, more severe diabetic-induced vascular impairment was developed than in male rats by impaired sympathetic mediated vasoconstriction or increase the relaxation to nitric oxide \[[@B3]\].

The activity of vascular sympathetic nervous system is regulated by adreneral hormone, several neurotransmitters and interaction with these factors via α~1~-, α~2~- and β-adrenoceptors \[[@B4]\]. In blood vessels, post-junctional α~1~-adrenoceptors play an important role in controlling vascular smooth muscle tone and thus modulate peripheral arterial resistance \[[@B5]-[@B7]\]. Radioligand binding, molecular cloning studies and isolated tissue experiments have identified three α~1~-adrenoceptor subtypes that are designated α~1A~, α~1B~, and α~1D~ \[[@B8],[@B9]\] and the functional dominance in adrenergic responses varies with tissue and species \[[@B10]\]. Considering these findings, diabetes-induced functional and distributional changes in the vascular α~1~-adrenoceptor can play a role in the pathogenesis of diabetic vascular disturbances, depending on the gender difference.

However, to our knowledge, there has been no investigation on how the α~1~-adrenoceptor subtypes change during the development of diabetic autonomic neuropathy depending on the gender. Therefore, we evaluated the effect of diabetes on function and distribution of the vascular α~1~-adrenoceptor using the distal mesenteric artery in streptozotocin (STZ)-induced diabetic male and female rats.

Materials and Methods
=====================

Animals
-------

Twenty-eight male and female Sprague-Dawley rats (8 weeks old, 200-250 g) were used. All animal studies were carried out in a semi-pathogen-free barrier zone at Institute for Laboratory Animal Research in accordance with the procedures outlined in the Guide for the Care and Use of Laboratory Animals.

Induction of diabetes mellitus
------------------------------

Male or female rats were randomly allocated into either the control group (n = 15) or diabetic group (n = 13). Diabetes was induced by a single intravenous tail vein injection of 60 mg/kg streptozotocin (STZ) dissolved in citrate buffer at pH 4.5. In the age-matched control groups, the same volume of citrate buffer was injected intravenously. All rats were housed in cages and allowed free access to food and water. Three days thereafter, blood glucose levels were measured from a drop of blood taken from the tail using OneTouch Ultra® Blood Glucose Meter (LifeScan, Inc). Rats with blood glucose \>300 mg/dl were considered diabetic. All rats were maintained for 4 weeks without intervention.

Changes in arterial blood pressure related to tilting
-----------------------------------------------------

Four weeks after STZ or citrate buffer injection, blood glucoses levels and body weights were measured. Body weights and blood glucose levels in normal and diabetic rats are shown in [Table 1](#T1){ref-type="table"}. Anesthesia was induced with sevoflurane-oxygen in a chamber and maintained with 2 vol% sevoflurane. Following anesthesia, rats were positioned in the supine position and four legs were firmly fixed on a tilt board. The tail artery was cannulated with a 24 G catheter for continuous arterial pressure monitoring. The transducer was positioned at the level of the heart. After measuring mean arterial pressure in the supine position (basal MAP), the table was vertically tilted at 45° angle in a head-up direction and MAP at 10, 30, 60, and 120 seconds after tilting were recorded. Changes in MAP related to tilting were compared at each time point between diabetic and control groups.

Preparation of vascular tissues
-------------------------------

After the tilting experiment, the rat was euthanized by cervical dislocation under deep anesthesia and the third branch of mesenteric artery was dissected. Arteries were placed in a Petri dish with ice-cold modified Krebs\' solution of the following composition (in mM): NaCl, 119; KCl, 4.7; MgSO~4~, 1.17; NaHCO~3~, 22; CaCl~2~, 1.6; HEPES, 8; KH~2~PO~4~, 1.18; d-glucose, 5. The artery was cleaned of fat and connective tissues under a microscope (Zeiss, Germany). To exclude the effect of endothelium-derived relaxing factor, the endothelium of the arteries was denuded by passing silk through the lumen. Thereafter, each artery was cut into 3 mm long rings for in vitro contractile studies. The remaining vessels were immediately stored at -80℃ for immunofluorescence staining and western blotting.

Measurements of isometric tension
---------------------------------

Each vascular segment, suspended between two triangle-shape tungsten hooks, was mounted in a 5 ml water-jacketed temperature-controlled tissue bath (Harvard Apparatus, Holliston, USA) containing modified Krebs\' solution. The lower and upper hooks were fixed to the bottom of the bath chamber and to a force displacement transducer, respectively (NP 72-4493, Harvard Apparatus, Holliston, USA). The tissue bathing solution was equilibrated and suspended with a mixture of 95% O~2~ and 5% CO~2~ (pH: 7.38-7.42, pCO2: 34-36 mmHg) and maintained at 37℃. Propranolol (1 × 10^-6^ M) and yohimbine (1 × 10^-7^ M) were always included in the tissue bathing solution to block β- and α~2~-adrenoceptors, respectively. Changes in isometric force were recorded through an A/D converter (Powerlab®, ADInstruments, Colorado Springs, USA) and analyzed by using Chart for Window Software® (ADInstruments, Colorado Springs, USA). Following an initial tension of 2.0 g, which provided the optimum concentration-response relationships to KCl 60 mM, the arterial strips were allowed to equilibrate for 60 min. When the resting tension reached a stable baseline, no attempt was made to adjust tissue tension. After the equilibrium, tissues were primed by the addition of phenylephrine (1 × 10^-6^ M) to the organ bath. After a steady-state contraction was achieved, bath contents were replaced with modified Krebs\' solution several times. Tissues were then allowed to reach baseline tension and the priming procedure was repeated once more before constructing concentration-response curves. This priming procedure reduces tissue variability in response to repeated agonist administration. In addition, the absence of functional endothelium was also confirmed by the loss of the relaxation response to acethylcholine (1 × 10^-6^ M) in the pre-contracted rings with a priming dose of phenylephrine (1 × 10^-6^ M) during the priming procedure.

Construction of concentration-response curves
---------------------------------------------

Reproducible cumulative concentration-response curves were constructed by exposing each artery to increasing concentrations of phenlyephrine (1 × 10^-9^ to 1 × 10^-4^ M at 0.5 log unit increments) until a sustained maximum response (Emax) was observed. Concentration-response curves to phenylephrine were then obtained (each at 60 min apart) in the presence of three selective α~1~-adrenoceptor antagonists to each artery and the procedure was repeated with a high concentration of antagonists in the same preparation. The incubation time for selective α~1~-adrenoceptor antagonists, prazosin (α~1~; 1, 3, and 10 × 10^-9^ M), 5-methylurapidil (5-MU; α~1A~; 3, 10, and 30 × 10^-8^ M), and BMY 7378 (α~1D~; 3, 10, and 30 × 10^-8^ M) was 30 min. Propranolol (1 × 10^-6^ M) and yohimbine (1 × 10^-7^ M) were always included in the tissue bath solutions to block β - and α~2~-adrenoceptors, respectively.

Immunofluorescence staining
---------------------------

After removing vessels and cleaning extraneous tissues, Hematoxylin and eosin (H&E) staining was used to assess the morphologic changes. Arteries were cut into 2-mm rings, embedded in OCT compound (Tissue-Tek® OCT™ Compound, Sakura Finetek, Japan) and quickly frozen (-50℃ in isopentane cooled with dry ice). Frozen blocks were cut into 5-µm sections and mounted on a slide. All sections were stored at -80℃ until use. After warming at room temperature for 30 minutes, the tissue sections were fixed in ice cold acetone for 5 minutes. After rinsing the sections in PBS, a blocking solution with 10% normal donkey serum was placed on the sections and then incubated for 30 minutes to block non-specific binding sites of immunoglobulin. After removal of the blocking solution, the tissue section was incubated with 1 : 100-diluted the primary antibody (α~1D~-AR cat. no. s.c.-1475, α~1A~-AR cat. no. s.c.-1477; Santa Cruz Biotechnology, Santa Cruz, USA) for 60 minutes at room temperature. After washing the primary antibody in PBS, fluoresceinisothiocyanate (FITC)-conjugated donkey anti-goat IgG (1 : 100 dilution, no. s.c.-2024; Santa Cruz Biotechnology) secondary antibody was placed on the sections for 60 minutes in the dark at room temperature. After removing secondary antibody by washing with PBS, mounting media was placed on the slide and a glass coverslip was adhered. To reduce the technical error, staining was performed on as same slide for each type of artery from each group. Three independent investigators observed the expression of α~1~-adrenoceptor subtypes of each artery with a fluorescence microscope (Olympus VENOX-AHBT3, Tokyo, Japan).

Western blotting
----------------

Isolated vascular segments were homogenized in lysis buffer (1% Nonidet-40, 20 mM Tris-HCl \[pH 7.4\], 150 mM NaCl, 1 mM Ethylenediaminetetracetic acid \[EDTA\], 0.1% SDS and 2 mM Phenylmethylsulfonyl fluoride \[PMSF\]). The sample was centrifuged at 12,000 g for 15 min at 4℃ and the supernatant was extracted. Protein concentrations were determined using the method of Sambrook and Russel \[[@B11]\]. Samples containing 180 ug of protein were boiled for 5 min to extract membrane proteins, loaded and electrophoresed on SDS-Polyacrolamide gels (PAGE), transferred to PVDF and then blocked for 1 h with 5% nonfat dry milk in tris-buffered saline with tween (TBST®; 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.05% Tween 20) for 1 hr at room temperature. Commercially available polyclonal antibodies to α~1A~- and α~1D~-adrenergic receptors (α~1A~-AR cat. no. s.c.-1477, α~1D~-AR cat. no. s.c.-1475; Santa Cruz Biotechnology) were applied to membranes (1 : 500 in TBST) overnight at 4℃. The membranes were washed with TBST® and secondary antibody diluted to 1 : 4,000 (Horse-radish peroxidase conjugated donkey anti-gout IgG; no. s.c.-2020; Santa Cruz Biotechnology) was incubated in room temperature with the membranes. After washing with TBST®, binding of the antibodies was detected with Chemiluminescent (ECL®, Amersham, Little Chalfont, Buckinghamshire, UK).

Statistical analysis
--------------------

Data are presented as means ± SD, means ± SEM, number of rats, or number of arterial segments. In each concentration-response curve, the changes in tension related to increasing concentrations of phenylephrine are expressed as the difference of tension (g) between the basal values and the measured value with various concentrations of phenylephrine. Curves were fitted to all the data by non-linear regression using GraphPad Prism software (GraphPAD software, San Diego, USA) to calculate the negative logarithm of the concentration of agonist that provokes a half-maximal response (pEC50 = agonist potency). A pA~2~ value and Schild slopes were calculated by the method of Arunlakshana and Schild \[[@B12]\]. Using three different concentrations of each antagonist, the ratios between the half-maximal concentrations (EC~50~) of phenylephrine obtained with the specific antagonist concentration and that obtained in its absence (concentration ratio, R) were calculated when the maximal amplitudes between concentration-response curves in those two conditions were similar. Data were plotted as negative log-concentrations of the antagonist on the x-axis vs. log (R-1) on y-axis and fitted as a regression line. For calculation purposes, the slope parameter was set to -1.0 when statistically not different from unity. The x-intercept of the fitted regression line was an estimated pA~2~. The value of pA~2~ presented a logarithmic measurement of the potency of the specific antagonist and also the dose of antagonist that required a 2-fold increase in agonist concentration. Data were compared by two-way ANOVA, followed by unpaired Student t test with the Bonferroni correction for multiple comparisons, to determine which comparisons were statistically significant. Data were considered significantly different at values of P \< 0.05.

Results
=======

Induction of diabetes mellitus and changes in arterial blood pressure related to tilting
----------------------------------------------------------------------------------------

Diabetic rats showed significantly higher blood glucose concentrations and lower body weight than age-matched normal rats ([Table 1](#T1){ref-type="table"}, all P \< 0.001). After a 45° tilting in the head-up direction, recovery of MAP was significantly slower in diabetic rats than in normal rats and recovery in normal female rats were significantly slower than in normal male rats ([Fig. 1](#F1){ref-type="fig"}, all P \< 0.05).

Concentration-response curves
-----------------------------

The concentration-response curves for phenylephrine-induced contraction of normal mesenteric artery showed that the Emax and -logEC~50~ in female rats were significantly lower than those in male rats ([Table 2](#T2){ref-type="table"}). Diabetic rats had the significantly lower Emax and -logEC~50~ than normal rats. Further, the Emax in diabetic female group was lower than that in diabetic male group but there was no significant difference in the -logEC~50~ ([Table 2](#T2){ref-type="table"}).

Regardless of arterial type, prazocin, 5-MU, and BMY 7378 shifted the concentration-response curve according to phenylephrine to the right in both diabetic and normal rats. In addition, pA~2~ values for prazocin, 5-MU, and BMY 7378 for inhibiting the contractile response to phenylephrine decreased by a similar order of magnitude in distal mesenteric arteries from diabetic rats (all P \< 0.001, [Table 3](#T3){ref-type="table"}). In normal female rats, the pA~2~ value for BMY 7378 was significantly smaller than in normal male rats.

Immunofluorescence staining and Western blotting
------------------------------------------------

H & E staining images in male and female mesenteric arteries from normal and streptozotocin-induced diabetic rats showed that diabetic mesenteric arteries were characterized by a decrease in density of muscle fiber at the media of the vessel wall ([Fig. 2](#F2){ref-type="fig"}). Immunofluorescence images of α~1A~- and α~1D~-adrenoceptor subtypes in mesenteric arteries of diabetic rats were characterized by a decreased fluorescent intensity ([Fig. 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}).

The α~1D~-adrenoceptor subtype was expressed less in female normal rats than in male normal rats ([Fig. 5](#F5){ref-type="fig"}). In diabetic rats, the expressions of the α~1A~- and α~1D~-adrenoceptor subtypes were decreased compared with those in the gender-matched normal rats (all P \< 0.05). In particular, in female diabetic rats, the expression of alpha~1D~ - receptors was not detectable above background.

Discussion
==========

The results of our study showed that diabetes impaired the MAP recovery after tilting irrespective of gender and the MAP changes after tilting were different between normal male and female rats. The concentration-response curves for phenylephrine-induced contraction of normal female mesenteric artery showed that the adrenergic-mediated vasocontraction was impaired via difference in α~1D~-adrenoceptor expression. In diabetic rats, the adrenergic mediated vasocontraction was decreased irrespective of gender, which might be caused by the general decrease in overall α~1~-adrenoceptor subtype expression.

Vascular α~1~-adrenoceptor plays a primary role in maintaining systemic arterial pressure and arteriolar resistance \[[@B5]-[@B7]\]. Recent studies have shown that the α~1D~-adrenoceptor plays a major role in vasoconstriction of mesenteric arteries \[[@B13],[@B14]\] and that the α~1A~-adrenoceptor is responsible for vascular contraction in distal mesenteric arteries \[[@B13]\]. A number of studies have demonstrated vascular differences depending of gender. Nitric oxide release which is an important endothelium-derived vasodilator regulating the vasomotor tone \[[@B15]\] depends on circulating estradiol concentrations \[[@B16]\]. In addition, estrogen decreases resistance artery adrenergic sensitivity by increasing the basal release of relaxing factors from the endothelium \[[@B17]\]. Our results in normal rats were comparable to a previous study \[[@B18]\] in which that the contractile responses to phenylephrine were significantly increased by endothelium disruption in arteries in males but not females. A possible explanation is that there was a significant difference in the pA~2~ for the α~1D~-adrenoceptor and normal female rats showed a relatively suppressed manifestation of α~1D~-adrenoceptor than normal males in immunofluorescence and western blotting. Similar to our results, the expression of α~1D~ - adrenergic receptors was significantly suppressed by estradiol replacement \[[@B19]\].

Diabetic male or female rats had a 15% lower Emax and 5 or 2 times higher EC~50~ for phenylephrine than did the controls. These were in close accordance with our immunofluorescence staining and western blotting results. There were some discrepancies about the adrenergic responses of the mesenteric arteries of STZ-rats. The conflicting results could be due to differences in the vascular responses between the superior mesenteric arteries and small mesenteric arteries as well as the intact mesenteric bed, where the latter more reflects the resistance arteries \[[@B20]\]. In addition, diabetic female mesenteric arteries had a 20% lower Emax than diabetic male. These results were similar with previous investigations in which contractile responses to phenylnephrine were higher in diabetic males than in female rats \[[@B21]\] and the sensitivity to adrenergic nerve stimulation was greater in males compared to females \[[@B22]\].

Diabetic rats showed impaired recovery from the tilt-induced decrease in blood pressure. This phenomenon is very comparable with orthostatic hypotension. Considering that orthostatic hypotension is the most serious clinical consequence of diabetes-induced vascular disturbances \[[@B23]\], our diabetic rat model would be appropriate for evaluating the effect of diabetes on the vascular alpha 1-adrenoceptor. In normal female rats, the MAP changes after tilting were significantly smaller than those in the other groups when assessed at 10 sec to 120 sec after tilting. On the contrary, most clinical studies report that the orthostatic hypotension in women occurs more frequently than normal men \[[@B24]-[@B26]\]. However, the smaller degree of MAP changes is in women \[[@B27],[@B28]\] and only changes in systolic BP to stimuli has gender differences \[[@B29]\]. A possible explanation is that the effects of α~2~ and β-adrenoceptors cannot be ruled out in vivo because the activity of vascular sympathetic nervous system is regulated by interaction via α~1~-, α~2~- and β-adrenoceptors \[[@B4]\].

Our study has some limitations. First, the α~1A~ and α~1D~ subtypes were chosen on the basis of their physiological roles in vivo in this study. It is reported that the contractions of the rat mesenteric artery are mediated via the α~1D~ and α~1A~-subtypes which werewas identified as the predominant subtypes in rat mesenteric arteries \[[@B13],[@B14]\]. In contrast, it appears that the α~1B~-subtype does not contribute to phenylephrine-induced pressor responses, nor may it be important for the maintenance of basal mean arterial pressure \[[@B30]\]. Second, 2 vol% sevoflurane may not result an equipotent depth of anesthesia between normal and diabetic rats when assessed in the tilting test. In diabetic rats, the decrease of vascular resistance by sevoflurane may be potentiated due to diabetes, which may make the difference greater.

In conclusion, the adrenergic-mediated vasocontraction was impaired via the decrease of α~1D~-adrenoceptors in normal female mesenteric arteries. Progression of diabetes decreased the contractile response in mesenteric arteries in STZ-induced diabetic rats irrespective of gender, which might be caused by the overall change in α~1~-adrenoceptors and not from the change in specific α~1~-adrenoceptor subtypes. Our results on the gender differences may be helpful in understanding one of the complex pathophysiologic changes in vascular disturbance caused by diabetes.
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![Time course for the change in mean arterial pressure (MAP) after tilting in normal male (▪), normal female (▴), streptozotocin-induced diabetic male (□) and diabetic female (▵) rats. Each data point represents means ± SD. Data from 13 rats were collected in each group. ^\*^P \< 0.001 vs. diabetic rats. ^†^P \< 0.05 vs. normal rats, ^‡^P \< 0.01 vs. male rats.](kjae-61-419-g001){#F1}

![Hematoxylin and eosin stained images in male (A, B) and female mesenteric arteries (C, D) from normal and streptozotocin-induced diabetic rats. (magnification: ×200). Mesenteric ar ter ies f rom diabet ic rat s were characterized by a decrease in density of muscle fiber at the media of the vessel wall.](kjae-61-419-g002){#F2}

![Immunofluorescence images of the α~1A~-adrenoceptor subtype in male (A, B) and female mesenteric arteries (C, D) from normal and streptozotocin-induced diabetic rats. (magnification: ×200). Diabetic mesenteric arteries were characterized by a decreased fluorescent intensity.](kjae-61-419-g003){#F3}

![Immunofluorescence images of the α~1D~-adrenoceptor subtype in male (A, B) and female mesenteric arteries (C, D) from normal and streptozotocin-induced diabetic rats. (magnification: ×200). Diabetic mesenteric arteries were characterized by a decreased fluorescent intensity.](kjae-61-419-g004){#F4}

![(A) A representative Western blot was shown in the top panel and the graphic presentation of alpha ~1~ - receptors quantified by integrating the volume of autoradiograms from three separate experiments is shown in the bottom panel. (B, C) In diabetic rats, the expressions of the alpha ~1A~ and alpha ~1D~ - receptors were suppressed compared with those in normal rats. (C) The expression of the alpha ~1D~ - receptors was suppressed in female normal rats compared with those in male normal rats. ^\*^P \< 0.05 vs. male rats. ^†^P \< 0.05 vs. normal rats.](kjae-61-419-g005){#F5}
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Body Weights and Blood Glucose Levels in Normal and Diabetic Rats
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Data are presented as means ± SD. ^\*^P \< 0.001 vs. male rats, ^†^P \< 0.001 vs. normal rats.
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Maximal Response (Emax) and -logEC~50~ Values for Phenylephrine-Induced Contraction of Distal Mesenteric Arteries from Normal and Streptozotocin-Induced Diabetic Rats
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Data are presented as means ± SD. EC~50~, the concentration of agonist that provokes a half-maximal response in the concentration-response curve. ^\*^P \< 0.001 vs. male rats, ^†^P \< 0.001 vs. normal rats.
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The pA~2~ Values Against Phenylephrine in Male or Female Distal Mesenteric Arteries from Normal and Streptozotocin-Induced Diabetic Rats
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Data are expressed as means ± SD. The value of pA~2~ represents a logarithmic measurement of the potency of the specific antagonist and also the dose of antagonist that required a 2-fold increase in agonist concentration. 5-MU: 5-methylurapidil. ^\*^P \< 0.001 vs. male rats. ^†^P \< 0.001 vs. normal rats.
